我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
393
9 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
2
0.5%
已完成
303
77.1%
Enrolling By Invitation
1
0.3%
尚未招募
6
1.5%
招募中
12
3.0%
暂停
终止
24
6.1%
Unknown
34
8.7%
撤回
10
2.5%
暂无批准数据
- UC San Diego received a $12.3 million, five-year NIDA grant to launch the Brain-FRAMe program targeting people with HIV and active methamphetamine use disorder. - The study will evaluate long-acting injectable ART combined with medication for addiction treatment (naltrexone plus bupropion) to improve viral suppression and reduce methamphetamine use. - A multidisciplinary framework spanning implementation science, pharmacology, virology, immunology, and neuroscience will study the same participants over a 52-week period. - The program aims to address a vulnerable population historically excluded from research and create a scalable public health model for restoring brain health.